These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7618926)

  • 1. Insulin and insulin-like growth factors in diabetes mellitus.
    Dunger DB
    Arch Dis Child; 1995 Jun; 72(6):469-71. PubMed ID: 7618926
    [No Abstract]   [Full Text] [Related]  

  • 2. Does recombinant human insulin-like growth factor I have a role in the treatment of type I (insulin dependent) diabetes during puberty?
    Dunger DB; Cheetham TD
    J Pediatr Endocrinol Metab; 1995; 8(4):237-42. PubMed ID: 8821899
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-like growth factor I: physiology, metabolic effects and clinical uses.
    Froesch ER; Hussain MA; Schmid C; Zapf J
    Diabetes Metab Rev; 1996 Oct; 12(3):195-215. PubMed ID: 8959385
    [No Abstract]   [Full Text] [Related]  

  • 4. Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
    Dunger DB; Cheetham TD; Holly JM; Matthews DR
    Acta Paediatr Suppl; 1993 Mar; 388():49-52; discussion 53. PubMed ID: 8329831
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin-like growth factor-I for the treatment of type 1 diabetes.
    Acerini CL; Dunger DB
    Diabetes Obes Metab; 2000 Dec; 2(6):335-43. PubMed ID: 11225962
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO; Dunger DB
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
    Møller N; Orskov H
    Lancet; 1997 Oct; 350(9086):1188-9. PubMed ID: 9652553
    [No Abstract]   [Full Text] [Related]  

  • 8. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes.
    Lanzetta P; Malara C
    Diabetes Care; 2000 Mar; 23(3):436-7. PubMed ID: 10868894
    [No Abstract]   [Full Text] [Related]  

  • 9. IGF-I and diabetes in adolescence.
    Dunger DB; Acerini CL
    Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of recombinant human insulin-like growth factor-I.
    Cotterill AM
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):11-5. PubMed ID: 1424187
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effects of insulin-like growth factor I with special reference to diabetes.
    Froesch ER; Hussain M
    Acta Paediatr Suppl; 1994 Apr; 399():165-70. PubMed ID: 7949607
    [No Abstract]   [Full Text] [Related]  

  • 12. Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes.
    Usala AL; Madigan T; Burguera B; Sinha MK; Caro JF; Cunningham P; Powell JG; Butler PC
    N Engl J Med; 1992 Sep; 327(12):853-7. PubMed ID: 1508245
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance.
    Froesch ER; Bianda T; Hussain MA
    Diabetes Metab; 1996 Jul; 22(4):261-7. PubMed ID: 8767173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
    Dunger DB; Acerini CL
    Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein anabolic action of insulin, growth hormone and insulin-like growth factor I.
    Russell-Jones DL; Umpleby M
    Eur J Endocrinol; 1996 Dec; 135(6):631-42. PubMed ID: 9025701
    [No Abstract]   [Full Text] [Related]  

  • 16. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human insulin-like growth factor I and treatment in diabetes].
    Koivisto VA
    Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks and benefits of insulin-like growth factor.
    Burguera B
    Ann Intern Med; 1994 Oct; 121(7):549; author reply 550. PubMed ID: 8067658
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.
    Cusi K; DeFronzo R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3077-84. PubMed ID: 10999789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.